|
Volumn 99 Suppl 1, Issue , 2012, Pages
|
[Association of radiotherapy and hormonotherapy in locally advanced prostate cancer].;Association hormonothérapie et radiothérapie dans le cancer de prostate localement avancé
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
CANCER GRADING;
CHEMICALLY INDUCED DISORDER;
HUMAN;
MALE;
METABOLIC BONE DISEASE;
METHODOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
PROSTATE TUMOR;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
RISK ASSESSMENT;
TIME;
ANDROGEN ANTAGONISTS;
BONE DISEASES, METABOLIC;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
NEOPLASM GRADING;
PROGNOSIS;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 84878923616
PISSN: None
EISSN: 17696917
Source Type: None
DOI: 10.1684/bdc.2012.1567 Document Type: Review |
Times cited : (6)
|
References (0)
|